KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Intangibles (2017 - 2025)

Historic Change in Intangibles for BeOne Medicines (ONC) over the last 5 years, with Q2 2025 value amounting to $20.0 million.

  • BeOne Medicines' Change in Intangibles changed N/A to $20.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 3674.28%. This contributed to the annual value of $4.7 million for FY2024, which is 7586.37% down from last year.
  • BeOne Medicines' Change in Intangibles amounted to $20.0 million in Q2 2025.
  • BeOne Medicines' 5-year Change in Intangibles high stood at $20.0 million for Q2 2025, and its period low was $4.7 million during Q1 2024.
  • Moreover, its 3-year median value for Change in Intangibles was $9.7 million (2023), whereas its average is $11.0 million.